Device Trial Radar · NCT01663363
Safety and Effectiveness of Wavefront-Guided LASIK Corrections of Myopic Refractive Errors
Last checked: Nov 20, 2026Latest source record: Feb 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
170
Actual
Start
Aug 2012
Primary completion
Mar 2014
Study completion Jul 2015
Sponsor
- Lead sponsor
- Abbott Medical OpticsPublic (ABT)
- Sponsor type
- Industry
- First posted
- Aug 13, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this clinical trial is to demonstrate that wavefront-guided LASIK is safe and effective for the correction of myopic refractive errors.
Conditions
- Myopia
Interventions
LASIK correction of myopic refractive errorsDevice
Surgeons will perform wavefront-guided LASIK based upon measurement obtained with the iDesign System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Eyes With Loss of More Than 2 Lines Best Spectacle Corrected Visual Acuity (BSCVA)Time frame: 6 Months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.